Jamadi Khiabani Mahsa, Soroushzadeh Sareh, Talebi Ardeshir, Samanta Ayan
Macromolecular Chemistry, Department of Chemistry─Ångström Laboratory, Uppsala University, Box 538, 751 21 Uppsala, Sweden.
Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran.
ACS Appl Mater Interfaces. 2024 Oct 8;16(41):55056-70. doi: 10.1021/acsami.4c08066.
injectable extracellular matrix (ECM) derived hydrogels that are suitable for cell encapsulation have always been the holy grail in tissue engineering. Nevertheless, these hydrogels still fall short today of meeting three crucial criteria: (a) flexibility on the injectability time window, (b) autonomous self-healing of the injected hydrogel, and (c) shape-retention under aqueous conditions. Here we report the development of a collagen-based injectable hydrogel, cross-linked by cycloaddition reaction between furan and maleimide groups, that (a) is injectable up to 48 h after preparation, (b) can undergo complete autonomous self-healing after injection, (c) can retain its shape and size over several years when stored in the buffer, (d) can be degraded within hours when treated with collagenase, (e) is biocompatible as demonstrated by cell-culture, and (f) is completely resorbable when implanted subcutaneously in rats without causing any inflammation.
适用于细胞封装的可注射细胞外基质(ECM)衍生水凝胶一直是组织工程领域的圣杯。然而,如今这些水凝胶仍未满足三个关键标准:(a)可注射时间窗口的灵活性;(b)注射后水凝胶的自主自我愈合;(c)在水性条件下的形状保持。在此,我们报告了一种基于胶原蛋白的可注射水凝胶的开发,该水凝胶通过呋喃和马来酰亚胺基团之间的环加成反应交联,其(a)在制备后长达48小时内可注射;(b)注射后可完全自主自我愈合;(c)储存在缓冲液中时,可在数年内保持其形状和大小;(d)用胶原酶处理后数小时内可降解;(e)细胞培养证明具有生物相容性;(f)皮下植入大鼠体内时可完全吸收,且不会引起任何炎症。